Nicole Mittmann1, Ning Liu2, Joan Porter2, Soo Jin Seung3, Pierre K Isogai3, Refik Saskin2, Matthew C Cheung4, Natasha B Leighl5, Jeffrey S Hoch6, Maureen Trudeau4, William K Evans7, Katie N Dainty8, Craig C Earle9. 1. Health Outcomes and PharmacoEconomic (HOPE) Research Centre, Sunnybrook Health Sciences Centre, Toronto, Ont. ; Department of Pharmacology, University of Toronto, Toronto, Ont. ; International Centre for Health Innovation, Richard Ivey School of Business, University of Western Ontario, London, Ont. 2. Institute for Clinical Evaluative Sciences, Toronto, Ont. 3. Health Outcomes and PharmacoEconomic (HOPE) Research Centre, Sunnybrook Health Sciences Centre, Toronto, Ont. 4. Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ont. 5. Princess Margaret Cancer Centre, University Health Network, Toronto, Ont. 6. Centre for Excellence in Economic Analysis Research, St. Michael's Hospital, Toronto, Ont. 7. Department of Oncology, McMaster University, Hamilton, Ont. 8. Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ont. 9. Institute for Clinical Evaluative Sciences, Toronto, Ont. ; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ont.
Abstract
BACKGROUND: The utilization and costs of home care services provided for people with colorectal cancer is not well-known. We conducted an analysis to determine the utilization and costs of such services associated with each stage of colorectal cancer among patients in the province of Ontario. METHODS: We included cases of colorectal cancer diagnosed in Ontario between Jan. 1, 2005, and Dec. 31, 2009. Data were extracted from the Ontario Cancer Registry and linked to data from a home care administrative database. The types of services used were stratified by stage of disease and by phase of care (initial phase = 180 d after diagnosis, terminal phase = 180 d before death, continuing phase = interval between initial and terminal phases). Overall utilization rates and costs were determined, and regression analysis was used to examine associated factors. RESULTS: A total of 36 195 patients had colorectal cancer diagnosed during the study period; the median age was 71 (interquartile range 61-79) years. Home care services were provided to 24 641 patients (68.1%). The number of services per patient-year was 27.5, at a cost of $2180 per patient-year. The number of services provided per patient-year increased with increasing disease severity at diagnosis (15.5 at stage I, 25.5 at stage II, 32.5 at stage III and 62.5 at stage IV; 22.6 for unstaged disease). The cost of services per patient-year also increased with disease severity at diagnosis ($1170 at stage I, $1995 at stage II, $2727 at stage III and $5541 at stage IV). Publicly funded home care services and associated costs decreased with increasing income group, but they increased among patients who had a history of high health resource utilization. The mean 30-day cost of home care services decreased from the initial phase of care ($323) to the continuing phase ($160) but increased during the terminal phase ($616). INTERPRETATION: More than two-thirds of the patients with colorectal cancer in this study used home care services. Those who received home care services used about 2 services per month in a one-year period, at a cost of about $2000 per year. This information can aid policy-makers in future decisions regarding resource allocations.
BACKGROUND: The utilization and costs of home care services provided for people with colorectal cancer is not well-known. We conducted an analysis to determine the utilization and costs of such services associated with each stage of colorectal cancer among patients in the province of Ontario. METHODS: We included cases of colorectal cancer diagnosed in Ontario between Jan. 1, 2005, and Dec. 31, 2009. Data were extracted from the Ontario Cancer Registry and linked to data from a home care administrative database. The types of services used were stratified by stage of disease and by phase of care (initial phase = 180 d after diagnosis, terminal phase = 180 d before death, continuing phase = interval between initial and terminal phases). Overall utilization rates and costs were determined, and regression analysis was used to examine associated factors. RESULTS: A total of 36 195 patients had colorectal cancer diagnosed during the study period; the median age was 71 (interquartile range 61-79) years. Home care services were provided to 24 641 patients (68.1%). The number of services per patient-year was 27.5, at a cost of $2180 per patient-year. The number of services provided per patient-year increased with increasing disease severity at diagnosis (15.5 at stage I, 25.5 at stage II, 32.5 at stage III and 62.5 at stage IV; 22.6 for unstaged disease). The cost of services per patient-year also increased with disease severity at diagnosis ($1170 at stage I, $1995 at stage II, $2727 at stage III and $5541 at stage IV). Publicly funded home care services and associated costs decreased with increasing income group, but they increased among patients who had a history of high health resource utilization. The mean 30-day cost of home care services decreased from the initial phase of care ($323) to the continuing phase ($160) but increased during the terminal phase ($616). INTERPRETATION: More than two-thirds of the patients with colorectal cancer in this study used home care services. Those who received home care services used about 2 services per month in a one-year period, at a cost of about $2000 per year. This information can aid policy-makers in future decisions regarding resource allocations.
Authors: J A Hayman; K M Langa; M U Kabeto; S J Katz; S M DeMonner; M E Chernew; M B Slavin; A M Fendrick Journal: J Clin Oncol Date: 2001-07-01 Impact factor: 44.544
Authors: Catherine Deri Armstrong; William E Hogg; Jacques Lemelin; Simone Dahrouge; Carmel Martin; Gary S Viner; Raphael Saginur Journal: Can Fam Physician Date: 2008-01 Impact factor: 3.275
Authors: Serge Dumont; Philip Jacobs; Konrad Fassbender; Donna Anderson; Véronique Turcotte; François Harel Journal: Palliat Med Date: 2009-10-16 Impact factor: 4.762
Authors: N Mittmann; P K Isogai; R Saskin; N Liu; J M Porter; M C Cheung; N B Leighl; J S Hoch; M E Trudeau; W K Evans; K N Dainty; C C Earle Journal: Curr Oncol Date: 2012-12 Impact factor: 3.677
Authors: Claire de Oliveira; Karen E Bremner; Reka Pataky; Nadia Gunraj; Kelvin Chan; Stuart Peacock; Murray D Krahn Journal: CMAJ Open Date: 2013-01-16
Authors: Ashley C Mays; Harrison G Bartels; Paul R Wistermayer; Matt L Rohlfing; Christopher M Gentile; Ralph D'Agostino; Joshua D Waltonen Journal: Head Neck Date: 2017-11-13 Impact factor: 3.147
Authors: N Mittmann; J M Porter; J Rangrej; S J Seung; N Liu; R Saskin; M C Cheung; N B Leighl; J S Hoch; M Trudeau; W K Evans; K N Dainty; C DeAngelis; C C Earle Journal: Curr Oncol Date: 2014-12 Impact factor: 3.677
Authors: Zhongkai Hu; Shiying Hao; Bo Jin; Andrew Young Shin; Chunqing Zhu; Min Huang; Yue Wang; Le Zheng; Dorothy Dai; Devore S Culver; Shaun T Alfreds; Todd Rogow; Frank Stearns; Karl G Sylvester; Eric Widen; Xuefeng Ling Journal: J Med Internet Res Date: 2015-09-22 Impact factor: 5.428
Authors: Claire De Oliveira; Reka Pataky; Karen E Bremner; Jagadish Rangrej; Kelvin K W Chan; Winson Y Cheung; Jeffrey S Hoch; Stuart Peacock; Murray D Krahn Journal: Healthc Policy Date: 2017-02
Authors: Iosief Abraha; Diego Serraino; Alessandro Montedori; Mario Fusco; Gianni Giovannini; Paola Casucci; Francesco Cozzolino; Massimiliano Orso; Annalisa Granata; Marcello De Giorgi; Paolo Collarile; Rita Chiari; Jennifer Foglietta; Maria Francesca Vitale; Fabrizio Stracci; Walter Orlandi; Ettore Bidoli Journal: BMJ Open Date: 2018-07-23 Impact factor: 2.692